Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Gemcitabine plus Cisplatin therapy"'
Autor:
Yusuke Wakasa, Yoshikazu Toyoki, Tomomi Kusumi, Yuma Kameyama, Tadashi Odagiri, Hiroyuki Jin, Makoto Nakai, Kazunori Aoki, Hiroaki Kawashima, Masaaki Endo
Publikováno v:
Surgical Case Reports, Vol 8, Iss 1, Pp 1-6 (2022)
Abstract Background Conversion surgery, which is defined as chemotherapy or chemoradiotherapy followed by radical surgery, may improve survival of patients with initially unresectable advanced biliary tract cancer, including gallbladder cancer. Howev
Externí odkaz:
https://doaj.org/article/4f252dbda58847ef9730c0233374ce9d
Autor:
Yuya Miura, Ryo Ashida, Teiichi Sugiura, Katsuhisa Ohgi, Mihoko Yamada, Shimpei Otsuka, Akiko Todaka, Katsuhiko Uesaka
Publikováno v:
Surgical Case Reports, Vol 8, Iss 1, Pp 1-9 (2022)
Abstract Background Conversion surgery for initially unresectable gallbladder cancer is rarely performed due to the low response rate for systemic chemotherapy, and a pathological complete response is seldom achieved. Case presentation A 67-year-old
Externí odkaz:
https://doaj.org/article/207edcfec739431d85999f69924eeb0b
Autor:
Sunisa Prasopporn, Orawan Suppramote, Ben Ponvilawan, Chanette Jamyuang, Jantappapa Chanthercrob, Amphun Chaiboonchoe, Pimkanya More-Krong, Kamonchanok Kongsri, Monthira Suntiparpluacha, Rawisak Chanwat, Krittiya Korphaisarn, Seiji Okada, Somponnat Sampattavanich, Siwanon Jirawatnotai
Publikováno v:
Frontiers in Oncology, Vol 12 (2023)
Externí odkaz:
https://doaj.org/article/ec0a8457396d49cb9b31dd5bb0eb9d12
Autor:
Sunisa Prasopporn, Orawan Suppramote, Ben Ponvilawan, Chanette Jamyuang, Jantappapa Chanthercrob, Amphun Chaiboonchoe, Pimkanya More-Krong, Kamonchanok Kongsri, Monthira Suntiparpluacha, Rawisak Chanwat, Krittiya Korphaisarn, Seiji Okada, Somponnat Sampattavanich, Siwanon Jirawatnotai
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Cholangiocarcinoma (CCA) is a highly lethal gastrointestinal malignancy that has one of the worst prognoses among solid tumors. The combination of Gemcitabine + Cisplatin (GEM/CIS) remains the standard first-line treatment for advanced stage CCA. How
Externí odkaz:
https://doaj.org/article/911c30605c684512880a37fea8fa7666
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Wakasa Y; Department of General Surgery, Aomori City Hospital, 1-14-20, Katta, Aomori, 030-0821, Japan. wa1022ka@yahoo.co.jp., Toyoki Y; Department of General Surgery, Aomori City Hospital, 1-14-20, Katta, Aomori, 030-0821, Japan., Kusumi T; Department of Pathology, Aomori City Hospital, Aomori, Japan., Kameyama Y; Department of General Surgery, Aomori City Hospital, 1-14-20, Katta, Aomori, 030-0821, Japan., Odagiri T; Department of General Surgery, Aomori City Hospital, 1-14-20, Katta, Aomori, 030-0821, Japan., Jin H; Department of General Surgery, Aomori City Hospital, 1-14-20, Katta, Aomori, 030-0821, Japan., Nakai M; Department of General Surgery, Aomori City Hospital, 1-14-20, Katta, Aomori, 030-0821, Japan., Aoki K; Department of General Surgery, Aomori City Hospital, 1-14-20, Katta, Aomori, 030-0821, Japan., Kawashima H; Department of General Surgery, Aomori City Hospital, 1-14-20, Katta, Aomori, 030-0821, Japan., Endo M; Department of General Surgery, Aomori City Hospital, 1-14-20, Katta, Aomori, 030-0821, Japan.
Publikováno v:
Surgical case reports [Surg Case Rep] 2022 Mar 25; Vol. 8 (1), pp. 50. Date of Electronic Publication: 2022 Mar 25.
Autor:
Miura Y; Division of Hepato-Biliary-Pancreatic Surgery, Shizuoka Cancer Center, 1007 Shimonagakubo, Nagaizumi-cho, Sunto-gun, Shizuoka, 411-8777, Japan., Ashida R; Division of Hepato-Biliary-Pancreatic Surgery, Shizuoka Cancer Center, 1007 Shimonagakubo, Nagaizumi-cho, Sunto-gun, Shizuoka, 411-8777, Japan. r.ashida@scchr.jp., Sugiura T; Division of Hepato-Biliary-Pancreatic Surgery, Shizuoka Cancer Center, 1007 Shimonagakubo, Nagaizumi-cho, Sunto-gun, Shizuoka, 411-8777, Japan., Ohgi K; Division of Hepato-Biliary-Pancreatic Surgery, Shizuoka Cancer Center, 1007 Shimonagakubo, Nagaizumi-cho, Sunto-gun, Shizuoka, 411-8777, Japan., Yamada M; Division of Hepato-Biliary-Pancreatic Surgery, Shizuoka Cancer Center, 1007 Shimonagakubo, Nagaizumi-cho, Sunto-gun, Shizuoka, 411-8777, Japan., Otsuka S; Division of Hepato-Biliary-Pancreatic Surgery, Shizuoka Cancer Center, 1007 Shimonagakubo, Nagaizumi-cho, Sunto-gun, Shizuoka, 411-8777, Japan., Todaka A; Division of Gastrointestinal Oncology, Shizuoka Cancer Center, Shizuoka, Japan., Uesaka K; Division of Hepato-Biliary-Pancreatic Surgery, Shizuoka Cancer Center, 1007 Shimonagakubo, Nagaizumi-cho, Sunto-gun, Shizuoka, 411-8777, Japan.
Publikováno v:
Surgical case reports [Surg Case Rep] 2022 Jan 26; Vol. 8 (1), pp. 20. Date of Electronic Publication: 2022 Jan 26.